Vantage Investment Advisors’s Scinai Immunotherapeutics SCNI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $140K | Buy |
250
+40
| +19% | +$22.4K | 0.03% | 180 |
|
|
2018
Q2 | $140K | Hold |
210
| – | – | 0.03% | 175 |
|
|
2018
Q1 | $114K | Hold |
210
| – | – | 0.03% | 183 |
|
|
2017
Q4 | $113K | Buy |
210
+20
| +11% | +$10.8K | 0.03% | 189 |
|
|
2017
Q3 | $136K | Buy |
190
+20
| +12% | +$14.3K | 0.04% | 164 |
|
|
2017
Q2 | $149K | Hold |
170
| – | – | 0.04% | 148 |
|
|
2017
Q1 | $99K | Hold |
170
| – | – | 0.03% | 178 |
|
|
2016
Q4 | $57K | Hold |
170
| – | – | 0.02% | 232 |
|
|
2016
Q3 | $62K | Hold |
170
| – | – | 0.03% | 220 |
|
|
2016
Q2 | $60K | Hold |
170
| – | – | 0.03% | 234 |
|
|
2016
Q1 | $63K | Hold |
170
| – | – | 0.03% | 220 |
|
|
2015
Q4 | $67K | Hold |
170
| – | – | 0.03% | 206 |
|
|
2015
Q3 | $62K | Buy |
+170
| New | +$62K | 0.04% | 206 |
|